Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schenone

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Experimental Oncology|October 13, 2024
GAP JUNCTION FUNCTION IS ESSENTIAL FOR SURVIVAL OF ACUTE LYMPHOBLASTIC LEUKEMIA CELLSE Edwards, D Schenone, U Sivagnanalingam, et al.
Revista Medica De Chile|December 1, 1995
[Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]L Thompson, M Pino, M A Castrillón, et al.
Cancer Medicine|February 28, 2014
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapyAaron D Schenone, Jingqin Luo, Luke Montgomery, et al.
The Journal of Biological Chemistry|June 12, 2010
Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residueEdoardo Fiorillo, Valeria Orrú, Stephanie M Stanford, et al.
Cell Death & Disease|October 14, 2016
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomasGregory R Bean, Jeff C Kremer, Bethany C Prudner, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Experimental Oncology|October 13, 2024
GAP JUNCTION FUNCTION IS ESSENTIAL FOR SURVIVAL OF ACUTE LYMPHOBLASTIC LEUKEMIA CELLSE Edwards, D Schenone, U Sivagnanalingam, et al.
Revista Medica De Chile|December 1, 1995
[Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]L Thompson, M Pino, M A Castrillón, et al.
Cancer Medicine|February 28, 2014
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapyAaron D Schenone, Jingqin Luo, Luke Montgomery, et al.
The Journal of Biological Chemistry|June 12, 2010
Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residueEdoardo Fiorillo, Valeria Orrú, Stephanie M Stanford, et al.
Cell Death & Disease|October 14, 2016
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomasGregory R Bean, Jeff C Kremer, Bethany C Prudner, et al.
Pageof 1